Clinical Trial: Brady MX a Quality Improvement Study

Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Observational [Patient Registry]

Official Title:

Brief Summary: Medtronic is sponsoring a quality improvement study called Brady MX. It is hypothesized that lack of awareness of treatment and diagnostics pathways result in lower number of referrals to implanters of IPG.

Detailed Summary:
Sponsor: Medtronic Cardiac Rhythm and Heart Failure

Current Primary Outcome: Absolute change in the proportion of subjects diagnosed with SND at pre specific time. [ Time Frame: 6 months ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Number of SND subjects receiving a referral for an indicated IPG device after the intervention [ Time Frame: 6 months ]

The change between subjects referred to an indicated IPG will be measured after the intervention in total number of patients that are referred correctly.


Original Secondary Outcome: Same as current

Information By: Medtronic Cardiac Rhythm and Heart Failure

Dates:
Date Received: July 18, 2016
Date Started: December 2016
Date Completion: October 2018
Last Updated: November 24, 2016
Last Verified: November 2016